Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment
Open Access
- 17 September 2012
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (40), 16348-16353
- https://doi.org/10.1073/pnas.1205226109
Abstract
Protein disulfide isomerase (PDI), an endoplasmic reticulum chaperone protein, catalyzes disulfide bond breakage, formation, and rearrangement. The effect of PDI inhibition on ovarian cancer progression is not yet clear, and there is a need for potent, selective, and safe small-molecule inhibitors of PDI. Here, we report a class of propynoic acid carbamoyl methyl amides (PACMAs) that are active against a panel of human ovarian cancer cell lines. Using fluorescent derivatives, 2D gel electrophoresis, and MS, we established that PACMA 31, one of the most active analogs, acts as an irreversible small-molecule inhibitor of PDI, forming a covalent bond with the active site cysteines of PDI. We also showed that PDI activity is essential for the survival and proliferation of human ovarian cancer cells. In vivo, PACMA 31 showed tumor targeting ability and significantly suppressed ovarian tumor growth without causing toxicity to normal tissues. These irreversible small-molecule PDI inhibitors represent an important approach for the development of targeted anticancer agents for ovarian cancer therapy, and they can also serve as useful probes for investigating the biology of PDI-implicated pathways.Keywords
This publication has 40 references indexed in Scilit:
- Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AMLBlood, 2011
- Disulfide bonds in ER protein folding and homeostasisCurrent Opinion in Cell Biology, 2011
- Phase I Dose-Escalation Study of the Pan-HER Inhibitor, PF299804, in Patients with Advanced Malignant Solid TumorsClinical Cancer Research, 2011
- Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteinsNature Chemical Biology, 2010
- Nitrosative Stress–Induced S-Glutathionylation of Protein Disulfide Isomerase Leads to Activation of the Unfolded Protein ResponseCancer Research, 2009
- Protein disulfide isomerases are antibody targets during immune-mediated tumor destructionBlood, 2009
- Increasing Melanoma Cell Death Using Inhibitors of Protein Disulfide Isomerases to Abrogate Survival Responses to Endoplasmic Reticulum StressCancer Research, 2008
- K2D2: Estimation of protein secondary structure from circular dichroism spectraBMC Structural Biology, 2008
- Reverse engineering of regulatory networks in human B cellsNature Genetics, 2005
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002